Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Pharma
Nubeka and Kerendia, the main growth drivers for Bayer’s pharmaceutical division, are performing even better…
The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1…
NoA Health has appointed former Novo Nordisk and Pfizer employee Luisa Li as CEO, putting…
Sanofi signs $1.5 billion worldwide license agreement for Sino Biopharm’s first-in-class JAK/ROCK assets
By healthadmin
Sanofi is betting $1.53 billion on Sino Biopharmaceutical’s new drug, securing global rights to a…
Pfizer CEO Dr. Albert Bourla, one of the most influential voices in the biopharmaceutical industry,…
The FDA has provided further insight into recent rejections submitted to two major pharmaceutical companies,…
Acadia Pharmaceuticals has not been silent about the recent rejection from the European Medicines Agency…
Esperion will pay more than $75 million to acquire Corstasis and newly approved Enbumyst
By healthadmin
At the JPMorgan Healthcare Conference in January, Esperion Therapeutics CEO Sheldon Koenig announced a vision…
With the launch of a key obesity drug underway in the United States, Novo Nordisk…
Pharmaceutical companies focus on safety and access to medicines as Middle East war breaks out
By healthadmin
As the effects of the weekend’s U.S. and Israeli attacks on Iran begin to reverberate…